The State of the Biopharmaceutical Industry – 2021

Affordable Networking & Training
02/12/2021
Online

Pharmaceutical Trends to Watch in 2021

2021 promises to be a year of continued innovation and change in the biopharmaceutical industry. While the biopharmaceutical sector has traditionally been labelled as highly resistant to recessions, COVID-19 has presented and will continue to present some daunting challenges, ranging from fast-paced digitalization to disruptions in supply chains and clinical trials.

As the COVID-19 pandemic continues to take its toll on businesses worldwide, pharmaceutical companies will be looking for new ways to create value, prepare for the future, and remain competitive in the ever-changing business landscape.

In this webinar Bonnie Bain, Global Head of Healthcare Operations and Strategy, Kitty Whitney, Director of Thematic Analysis, and Urte Jakimaviciute, Senior Director of Market Research, will indicate the top trends that are going to shape pharmaceutical industry in 2021. The webinar will cover the most impactful emerging technologies, industry, regulatory, and microeconomic factors that are going to impact industry’s performance and growth prospects.

The webinar will include insights from pharmaceutical industry respondents that were surveyed for GlobalData’s “The State of the Biopharmaceutical Industry – 2021” report, followed by a Q&A session.

Presented by

Bonnie Bain,

Global Head of Healthcare Operations and Strategy

Bornadata (Bonnie) Bain, PhD is the Global Head and EVP of Healthcare Operations and Strategy. Bonnie has almost 20 years’ experience in the healthcare sector and a proven track record of developing innovative solutions on both the client and agency sides of the business. Bonnie was GlobalData Healthcare’s first Western analyst and under her leadership, the company launched a number of premium syndicated reports, analytical tools and databases in the pharmaceuticals and medical devices space. Prior to GlobalData, Bonnie was Vice President and Global Research & Analysis Director for Informa’s Pharma Division, which includes Datamonitor Healthcare, Scrip Group, and Business Insight. Bonnie also worked for several years at Decision Resources as an Analyst and Project Manager. On the client side of the industry, Bonnie worked for several years as a Senior Manager in Marketing Strategy and Analytics at Boston Scientific where her work contributed to the successful commercialization of the first ever Access and Visualization Platform at the company. Bonnie has a PhD in Biochemistry and Molecular Biology from Purdue University and completed a Post-Doctoral Fellowship in Molecular Pharmacology at the University Of Miami School Of Medicine. She also has a graduate certificate in Applied Management Principles from Purdue University Krannert School of Management.

Kitty Whitney,

Director of Thematic Analysis

Kathryn (Kitty) Whitney, MSc, is Director of Thematic Analysis in the healthcare division of GlobalData, London, where she is responsible for delivering all research projects within the space. Previously, she was the Principal Analyst for Digital Marketing Intelligence and Infectious Disease & Metabolic teams at Sociable Pharma. Kathryn’s pharmaceutical industry knowledge is comprehensive, gained from her time working within Healthcare at Home’s business strategic group, as well as her time in analysis positions at Intelligentsia Worldwide and IMS Health. Prior to this, Kathryn worked within biotechnology commercialization at both UCB and Wyeth. Kathryn has an MSc in Biotechnology from University College Galway (Ireland), and a BSc in Plant & Microbial Biotechnology from University College Cork (Ireland).

Urte Jakimaviciute,

Senior Director of Market Research

Urte Jakimaviciute, MSc, is Senior Director of Market Research in the healthcare division at GlobalData, London. Her primary responsibility includes managing the market research process for the syndicated portfolio, thematic reports, and custom consulting projects. Urte has more than 10 years of experience in the market research industry; her experience is evenly split between qualitative and quantitative methodologies. Prior to GlobalData, she held management roles at market research agencies providing consulting and market research services to the healthcare/technology industries. Urte holds a MS in Economics from the LUISS Guido Carli University, Italy and BA in Information Management Systems from Vilnius University, Lithuania.

Key Learning Objectives

  • Assess the impact of the COVID-19 pandemic on the biopharmaceutical sector
  • Identify industry themes that will have the greatest positive or negative impact in 2021
  • Learn which emerging technologies are expected to transform pharmaceutical sector
  • Determine how quickly pharmaceutical sector can recover from COVID-19 impact

Audience

  • Managers/Senior Managers/Associate Directors/Directors of Market Research
  • Business Insights
  • Market Intelligence
  • Strategic Insights
  • Forecasting
  • Competitive Strategy
  • Customer Insights
  • Heads of Research and Development
  • Heads of Product Planning and Marketing
  • Brand Managers
  • Market Access
  • Health Economics and Outcomes Research
  • Pharmaceutical Pricing
  • Pharmaceutical Licensing
  • Government and Public Affairs
  • Drug Development
  • Regulatory Affairs
  • Medical Affairs
  • Market Access Consultant

Register Now

Comment